Smart Ring Maker Oura Aims to Raise ₹18,300 Crore in US IPO
Source: Economictimes
Arth Insight · What this means for your wallet
- Oura, the smart ring maker, plans to raise up to ₹18,300 crore in its US IPO.
- Shares will be priced between $40 and $44, with 50 million shares offered.
- Eli Lilly and Dragoneer have shown interest in buying shares.
Oura, the company behind the popular smart health tracking ring, is planning to raise up to ₹18,300 crore (approximately $2.2 billion) through its Initial Public Offering (IPO) in the United States. Existing investors and the company will sell 50 million shares, with a price range set between $40 and $44 per share. Pharmaceutical giant Eli Lilly and investment firm Dragoneer have expressed interest in buying shares.
- ▸Oura, the smart ring maker, plans to raise up to ₹18,300 crore in its US IPO.
- ▸Shares will be priced between $40 and $44, with 50 million shares offered.
- ▸Eli Lilly and Dragoneer have shown interest in buying shares.
- ▸This IPO reflects strong investor interest in health technology and wearable devices.
- ✓Oura, the smart ring maker, plans to raise up to ₹18,300 crore in its US IPO.
- ✓Shares will be priced between $40 and $44, with 50 million shares offered.
- ✓Eli Lilly and Dragoneer have shown interest in buying shares.
- ✓This IPO reflects strong investor interest in health technology and wearable devices.
Smart ring manufacturer Oura is set to launch its Initial Public Offering (IPO) in the United States, with an ambitious target of raising up to ₹18,300 crore (approximately $2.2 billion). The company, known for its innovative smart rings that monitor crucial health indicators like heart rate and sleep patterns, is offering 50 million shares to the public.
IPO Details and Investor Interest
The shares are expected to be priced in a range of $40 to $44 each. This offering will include shares sold by Oura itself, alongside those from some of its existing investors. Notably, two significant entities, pharmaceutical giant Eli Lilly and investment firm Dragoneer, have already indicated their interest in purchasing shares during the IPO.
What is Oura?
Oura Health Oy is a Finnish health technology company that develops and manufactures the Oura Ring, a wearable device designed to track sleep, activity, and overall health. The ring collects data on heart rate, heart rate variability, body temperature, and movement, providing users with insights into their well-being through a companion app. It has gained popularity among health enthusiasts and athletes for its discreet design and comprehensive health tracking capabilities.
Implications for Global Markets
This IPO marks a significant event in the wearable technology and health tech sectors. A successful listing could provide Oura with substantial capital to further its research and development, expand its product offerings, and increase its market penetration globally. For Indian investors tracking global markets, Oura's IPO offers a glimpse into the valuation trends and investor appetite for innovative health technology companies.
Why This Matters for Indian Readers
While this is a US-based IPO, the performance of companies like Oura on international exchanges can influence investor sentiment towards similar technology and health-focused companies in India. It also highlights the growing global trend of integrating technology into personal health management, a trend that is increasingly visible in the Indian market with the rise of fitness trackers and smart wearables.
This report is for informational purposes only and does not constitute investment advice.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.
Frequently Asked Questions
What is Oura and what does it do?
Oura is a Finnish health technology company that makes a smart ring. This ring tracks key health indicators like heart rate, sleep patterns, and body temperature to provide users with insights into their well-being.
How much money is Oura looking to raise in its IPO?
Oura aims to raise up to ₹18,300 crore (approximately $2.2 billion) through its Initial Public Offering in the United States.
Who are the key investors interested in Oura's IPO?
Pharmaceutical company Eli Lilly and investment firm Dragoneer have indicated their interest in purchasing shares in Oura's IPO.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Global Markets
San Francisco Fed Study: El Niño Could Push US Inflation Up 1% by 2027
A study from the San Francisco Federal Reserve indicates that the current strong El Niño weather pattern could increase US inflation by 1 percentage point in 2027. This forecast, despite a temporary boost to employment, adds pressure on the US central bank to potentially raise interest rates, as inflation already exceeds its 2% target.
Kimberly-Clark Finalises Kenvue Acquisition, Eyes Growth in Consumer Health
Global consumer goods leader Kimberly-Clark has officially completed its acquisition of Kenvue, the company renowned for products like Tylenol. This strategic move aims to boost Kimberly-Clark's future growth and enhance its earnings. The development marks a significant consolidation within the global consumer health sector.
AI & Tech Stock Declines Overshadow Wall Street Gains
Significant declines in artificial intelligence (AI) and technology stocks are currently overshadowing positive movements across most other sectors on Wall Street. This trend highlights a divergence in the US equity market, where specific high-profile segments are facing headwinds despite broader market strength.
Related Stories
San Francisco Fed Study: El Niño Could Push US Inflation Up 1% by 2027
A study from the San Francisco Federal Reserve indicates that the current strong El Niño weather pattern could increase US inflation by 1 percentage point in 2027. This forecast, despite a temporary boost to employment, adds pressure on the US central bank to potentially raise interest rates, as inflation already exceeds its 2% target.
Kimberly-Clark Finalises Kenvue Acquisition, Eyes Growth in Consumer Health
Global consumer goods leader Kimberly-Clark has officially completed its acquisition of Kenvue, the company renowned for products like Tylenol. This strategic move aims to boost Kimberly-Clark's future growth and enhance its earnings. The development marks a significant consolidation within the global consumer health sector.
AI & Tech Stock Declines Overshadow Wall Street Gains
Significant declines in artificial intelligence (AI) and technology stocks are currently overshadowing positive movements across most other sectors on Wall Street. This trend highlights a divergence in the US equity market, where specific high-profile segments are facing headwinds despite broader market strength.
US Stocks See Partial Recovery as Global Oil Prices Drop Sharply
US equity markets experienced a partial rebound, regaining some of the losses from the previous week's sell-off. This upward movement coincided with a significant decline in international crude oil prices, offering some relief to investor sentiment.